Skip to main content

Table 4 Accelerated failure time model for the novel and standard method with test dataset (NCT02499770)

From: Segmentation of patients with small cell lung cancer into responders and non-responders using the optimal cross-validation technique

Novel Method

HR

exp(c) lower\(95\%\)

exp(c) upper\(95\%\)

p

Covariate

    

 Age

0.849

0.708

1.019

0.078

 PC2

0.906

0.801

1.026

0.120

 Race

5.752

2.559

12.931

<0.0005

 Sex

1.910

1.531

2.382

<0.0005

 Smoke

0.028

0.002

0.509

0.016

 Weight

1.011

1.001

1.021

0.031

 Group

1.254

1.053

1.493

0.011

Standard Method

HR

exp(c) lower\(95\%\)

exp(c) upper\(95\%\)

p

Covariate

    

 Age

0.936

0.835

1.049

0.255

 PC2

0.266

0.008

9.025

0.461

 Race

0.352

0.233

0.533

<0.0005

 Sex

0.316

0.221

0.451

<0.0005

 Smoke

0.706

0.548

0.910

0.007

 Weight

0.969

0.945

0.993

0.011

 Group

1.107

0.934

1.311

0.240